For decades, medical cancer treatment has generally meant chemotherapy, radiation, or surgery, alone or in combination. Today, new approaches such as immunotherapies and targeted therapies are becoming available, with many more in research and development.

Health challenges across the globe — everything from climate change to infectious disease and better treatment options for patients — precipitate the need for skilled physician-scientists: physicians who see patients in the clinic and who also devote time to scientific research. Duke programs including the Office of Physician-Scientist Development and the Medical Scientist Training Program are helping to meet that need.

As the new chief patient officer at the American Cancer Society, Arif Kamal is working to ensure that cancer treatment goes beyond providing the appropriate therapy and also addresses each patient’s individual circumstances.

2019 Nobel Prize winner Bill Kaelin says he’d be disappointed if he could predict the next big thing in cancer research and care, because many of the greatest advances come from unexpected directions.

Eugenie S. Kleinerman, chair of the Division of Pediatrics at the University of Texas MD Anderson Cancer Center, is exploring how to alter the tumor microenvironment to increase the efficacy of treatments and improve outcomes.

Lori Pierce, a radiation oncologist, professor, and vice provost for academic and faculty affairs at the University of Michigan, says there is an important but frequently misunderstood distinction between “equality of care” and “equity of care.”

We reach for cough drops when we’re sick, pain cream for aches, breath mints to freshen up, eye drops for dry eyes, and cold packs to ease inflammation after injury.

Duke University and the National University of Singapore (NUS) today reaffirmed their commitment to Duke-NUS Medical School -- Singapore’s flagship graduate-entry, research-focused medical school -- by renewing their partnership agreement.

Duke University cardiology researchers are teaming up with North Carolina emergency care personnel—EMS, fire, police, 911 dispatch and community members—across the state in a pragmatic cluster-randomized trial that will test community interventions to improve survival for out of hospital cardiac arrest, a leading cause of death in the U.S.

Anru Zhang, PhD, hopes to give physicians another tool to treat disease and improve health – by turning patients’ electronic medical records into a treasure trove of information.